CANY
PAHC icon

Caxton Associates (New York)’s Phibro Animal Health PAHC Stock Holding History

Caxton Associates (New York)’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-7,869
Closed -$250K – 502
2019
Q2 		$250K Hold
7,869
– – 0.03% 324
2019
Q1 		$260K Buy
+7,869
New +$245K 0.04% 291

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return

Caxton Associates (New York)'s PAHC Position: Q3 2019 in Review

Caxton Associates (New York) sold out of Phibro Animal Health (PAHC) in Q3 2019, closing a stake of 7,869 shares — an estimated $250K sold.

Caxton Associates (New York) first reported a position in PAHC in Q1 2019 and held it in 2 quarters. The position peaked at $260K in Q1 2019. 153 funds tracked by Wall St. Rank hold PAHC as of Q3 2019.

  • Caxton Associates (New York) reported no remaining Phibro Animal Health position as of Q3 2019 after selling out during the quarter.
  • Caxton Associates (New York) sold 7,869 Phibro Animal Health shares in Q3 2019, an estimated $250K.
  • Caxton Associates (New York) first reported a position in Phibro Animal Health in Q1 2019 and held it in 2 quarters.
  • Caxton Associates (New York)'s Phibro Animal Health position peaked at $260K in Q1 2019.
  • 153 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2019.

Based on Caxton Associates (New York)'s 13F filing for Q3 2019, filed 14 Nov 2019.